Pharmacy Technician Bridging Education Program-Course and PLAR exam schedules
Please note, this section will be updated periodically as the information becomes available.
Reminder: Courses and PLAR exams available in both English and French
NOTE: Selkirk College registration deadline for all English and French courses beginning in April 2015 is April 9, 2015
Rappel : Les cours et les examens ERA sont offerts en français et en anglais
REMARQUE : La date limite pour l’inscription aux cours (anglais et français) débutant en avril 2015 au collège Selkirk est le 9 avril 2015
Registration deadlines for all institutions are available on the Course and PLAR Schedules page.
Registration for all courses is conducted directly with the educational institution offering the program.
NDSAC Meeting of March 15-16, 2015
The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for March 15-16, 2015 is cancelled.
The next meeting of the Committee is scheduled for June 14-15, 2015. The deadline to receive submissions for a drug scheduling application for this meeting is by end of day Wednesday, April 15, 2015.
NAPRA Notes - Winter 2015
The most recent edition of NAPRA Notes is now available.
NAPRA Notes - Winter 2015
Skin-cancer drug Zelboraf (vemurafenib): new warning on the risk of pancreatitis
A new warning has been added to the Canadian prescribing information for the skin-cancer drug Zelboraf (vemurafenib) advising of the risk of pancreatitis.
Health Canada Information Update
Health Professional Communication
Cefazolin for Injection USP 1 g - May Contain Foreign Particulate Matter and Sterility May be Compromised - Apotex Inc.
Two lots of Cefazolin for Injection USP 1 g (lots 117E006 and 117E005) manufactured by Hospira and distributed in Canada by Apotex Inc., are being voluntarily recalled, due to the potential presence of foreign particulate matter. Inadvertent injection of foreign particulate matter and the potential that sterility has been compromised for these lots could result in risks to health.
Health Canada Health Professional Communication
Unauthorized health products that may pose health risks removed from sale by Health Canada
Two unauthorized health products that may pose serious health risks were removed from sale by Health Canada. These products, “MRM DHEA” and “Altimate Fat Burner Maximum Burn” were being sold by Nature’s Source, Unit #7, 2943 Major Mackenzie Drive, Vaughan, Ontario.
Health Canada Advisory
Health Product Risk Communication
Risperidone - Restriction of the Dementia Indication - Janssen Inc.
The indication for risperidone in dementia has been restricted to the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type. The indication no longer includes the treatment of other types of dementia.
Health Canada Health Product Risk Communication
Health Products Risk Communication
Olanzapine - Voluntarily Recalled Lots of Tablets by Pharmascience Inc. and Pro Doc Limitée
Seven lots of olanzapine distributed by Pharmascience Inc. and Pro Doc Limitée are being voluntarily recalled. There is a possibility that bottles from the recalled lots may contain tablets of a different drug, ondansetron.
Health Canada Health Products Risk Communication